Cognition Therapeutics, Inc.

NASDAQ:CGTX

Biotechnology

Healthcare
$0.60 -0.70%

-$0.01 today

Market cap
$57.12M
Beta
1.75
P/E (TTM)
-6.4
EPS (TTM)
-$0.22
52W Low $0.25High $3.83

Volume 0.33M

Average 1.23M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$47.80M

FY 2025 · Annual

Net Income

-$23.49M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0235K000
Gross Profit0(235K)000
Gross Margin—————
Research & Development18.57M30.32M37.2M41.68M37.19M
Selling, General & Admin10.03M13.23M13.53M12.29M10.61M
Operating Expenses28.6M43.32M50.72M53.97M47.8M
Depreciation & Amortization93K235K252K266K228K
EBITDA(10.73M)(21.13M)(25.51M)(33.68M)(23.25M)
EBITDA Margin—————
Operating Income(28.6M)(43.55M)(50.72M)(53.97M)(47.8M)
Operating Margin—————
Interest Income17.45M22.22M24.81M00
Interest Expense893K28K27K25K13K
Other Income / Expenses16.88M22.15M24.94M20M24.31M
Income Before Tax(11.72M)(21.4M)(25.79M)(33.97M)(23.49M)
Pre-Tax Margin—————
Income Tax Expense0(22.15M)000
Net Income(11.72M)757K(25.79M)(33.97M)(23.49M)
Net Margin—————
EPS (Basic)(0.73)(0.74)(0.86)(0.85)(0.32)
EPS (Diluted)(0.73)(0.74)(0.86)(0.85)(0.32)
Weighted Avg Shares22.23M28.99M29.99M39.73M72.77M
Weighted Avg Shares (Diluted)22.23M28.99M30.03M39.73M72.77M

CGTX Earnings Waterfall · TTM

NASDAQ:CGTX · Revenue to Net Income

Key Ratios

EPS$-0.26
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$19.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.26, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportOct 22, 2026
10-QQuarterly reportAug 7, 2026
8-KCurrent reportAug 6, 2026

How much revenue does CGTX generate?

Cognition Therapeutics, Inc. (CGTX) reported $0.00 of revenue in fiscal 2025.

Is CGTX profitable?

Cognition Therapeutics, Inc. (CGTX) reported -$23.49M of net income.